MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 57 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,002,512 | +55.9% | 3,102,723 | +59.5% | 0.34% | +130.9% |
| Q2 2023 | $2,567,453 | +76.9% | 1,945,040 | -5.2% | 0.15% | -32.0% |
| Q1 2023 | $1,451,060 | -5.7% | 2,052,709 | 0.0% | 0.22% | -20.4% |
| Q4 2022 | $1,539,532 | -54.8% | 2,052,709 | -48.1% | 0.28% | -32.4% |
| Q3 2022 | $3,407,000 | -0.6% | 3,957,135 | +29.4% | 0.41% | -8.1% |
| Q2 2022 | $3,426,000 | +135.0% | 3,058,596 | +135.0% | 0.44% | +163.7% |
| Q1 2022 | $1,458,000 | +32.8% | 1,301,783 | +89.7% | 0.17% | +38.8% |
| Q4 2021 | $1,098,000 | – | 686,292 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,854,278 | $6,638,000 | 3.61% |
| Asymmetry Capital Management, L.P. | 739,812 | $2,649,000 | 1.21% |
| Affinity Asset Advisors, LLC | 625,000 | $2,238,000 | 1.19% |
| Tri Locum Partners LP | 728,710 | $2,609,000 | 0.95% |
| Boxer Capital, LLC | 6,226,673 | $22,291,000 | 0.72% |
| DAFNA Capital Management LLC | 668,148 | $2,392,000 | 0.71% |
| Vivo Capital, LLC | 4,220,938 | $15,111,000 | 0.67% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $919,000 | 0.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 280,000 | $1,002,000 | 0.58% |
| Rubric Capital Management LP | 1,853,417 | $6,635,000 | 0.49% |